SCHEMBL484649

SCHEMBL484649

N#CC1C(=O)NC(=O)C(C#N)C12CCCN(Cc1ccccc1)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.47
SIGMAR1 Q99720 7/20 0.45
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
HIF1A Q16665 1/20 0.43
CYP3A4 P08684 1/20 0.43
HSD17B10 Q99714 1/20 0.43
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
CYP2D6 P10635 1/20 0.42
OPRL1 P41146 2/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
BACE1 P56817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2202948 0.95 OPRM1 (0.51) OPRM1SIGMAR1ALDH1A1TSHRMEN1
SCHEMBL13131356 0.88 OPRM1 (0.47) OPRM1SIGMAR1ALDH1A1TSHRMEN1
SCHEMBL4187348 0.77 CYP3A4 (0.53) OPRM1SIGMAR1ALDH1A1TSHRMEN1
SCHEMBL6623233 0.74 ALDH1A1 (0.51) ALDH1A1TSHRMEN1KMT2AHIF1A
SCHEMBL19112477 0.70 ALDH1A1 (0.44) ALDH1A1TSHRLMNAGAAHPGD
SCHEMBL2203805 0.70 GRIN1 (0.50) OPRM1SIGMAR1ALDH1A1TSHRLMNA
SCHEMBL18845206 0.70 CYP2D6 (0.48) OPRM1ALDH1A1TSHRMEN1CYP2C9
SCHEMBL17714554 0.70 OPRM1 (0.58) OPRM1SIGMAR1ALDH1A1TSHRMEN1
SCHEMBL18845203 0.68 ACHE (0.57) OPRM1SIGMAR1OPRL1OPRK1BACE1
Water SCHEMBL17460165 0.68 SIGMAR1 (0.77) SIGMAR1CYP2C19CYP3A4HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN OPRM1 799/4885SIGMAR1 572/4885ALDH1A1 2086/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN OPRM1 799/4885SIGMAR1 572/4885ALDH1A1 2086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.